Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho

(2020) Andrew Bryan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Serological tests facilitate identification of asymptomatic SARS‐CoV‐2 infection in Wuhan, China

(2020) Xiaodong Wu et al.   JOURNAL OF MEDICAL VIROLOGY

Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection

(2020) K.L. Chew et al.   CLINICAL MICROBIOLOGY AND INFECTION

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

(2020) Thomas Nicol et al.   JOURNAL OF CLINICAL VIROLOGY

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

(2020) Silvia Stringhini et al.   LANCET

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

(2020) Marina Pollán et al.   LANCET

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

(2020) Xin Xu et al.   NATURE MEDICINE

Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China

(2020) Fan Wu et al.   JAMA Internal Medicine

Use of serological surveys to generate key insights into the changing global landscape of infectious disease

(2016) C Jessica E Metcalf et al.   LANCET